Search by Drug Name or NDC

    NDC 00002-8980-05 Rezvoglar 100 [iU]/mL Details

    Rezvoglar 100 [iU]/mL

    Rezvoglar is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is INSULIN GLARGINE.

    Product Information

    NDC 00002-8980
    Product ID 0002-8980_615b8713-dfda-4f22-b544-51550aecee4b
    Associated GPIs
    GCN Sequence Number 082926
    GCN Sequence Number Description insulin glargine-aglr INSULN PEN 100/ML (3) SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 51718
    HICL Sequence Number 047733
    HICL Sequence Number Description INSULIN GLARGINE-AGLR
    Brand/Generic Brand
    Proprietary Name Rezvoglar
    Proprietary Name Suffix KwikPen
    Non-Proprietary Name Insulin glargine-aglr
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN GLARGINE
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Insulin Analog [EPC], Insulin [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761215
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-8980-05 (00002898005)

    NDC Package Code 0002-8980-05
    Billing NDC 00002898005
    Package 5 SYRINGE in 1 CARTON (0002-8980-05) / 3 mL in 1 SYRINGE (0002-8980-01)
    Marketing Start Date 2021-12-17
    NDC Exclude Flag N
    Pricing Information N/A